Zheng, J., Zhao, S., Yu, X., Huang, S., & Liu, H. Y. (2017). Simultaneous targeting of CD44 and EpCAM with a bispecific aptamer effectively inhibits intraperitoneal ovarian cancer growth. Theranostics.
Dyfyniad Arddull ChicagoZheng, Jingying, Shuhua Zhao, Xiaolin Yu, Shuang Huang, and Hong Yan Liu. "Simultaneous Targeting of CD44 and EpCAM With a Bispecific Aptamer Effectively Inhibits Intraperitoneal Ovarian Cancer Growth." Theranostics 2017.
Dyfyniad MLAZheng, Jingying, et al. "Simultaneous Targeting of CD44 and EpCAM With a Bispecific Aptamer Effectively Inhibits Intraperitoneal Ovarian Cancer Growth." Theranostics 2017.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.